A Randomised Study Comparing No Mechanical Bowel Preparation With Oral Antibiotics Alone in Patients Undergoing Elective Colon Surgery (REaCT-NSQIP)
试验速览
- 阶段
- 4 期
- 状态
- 进行中(未招募)
- 入组人数
- 630
- 试验地点
- 13
- 主要终点
- Post-Operative Surgical Infection Complication
研究概览
简要总结
The REaCT NSQIP will compare oral antibiotics vs. no antibiotics, which are two standards of care treatments for preoperative preparation of the bowel prior to colorectal surgery
详细描述
The divergence of clinical practice guidelines, in addition to observation from the large North American retrospective studies, suggest that surgeons and centers have not established a standard of care for the preoperative preparation of the bowel prior to colorectal surgery. Specifically, some centers are employing no preparation, others are administering a mechanical bowel preparation (MBP) and oral antibiotics and still others are using oral antibiotics alone. Recently, the Canadian Society of Colorectal Surgeons was unable to come to a consensus when attempting to update their preoperative guidelines because of the lack of agreement on best practice (personal communication). This is an important yet controversial topic in colorectal surgery and a clinical trial comparing two standard of care therapies will impact current practice in Canada. The REaCT-NSQIP study compares post-operative surgical infectious complications, length of stay, incidence of C. difficile rates, patient quality of life and cost-effectiveness in patients undergoing elective colorectal surgery with either no preparation or oral antibiotics. Data will be collected from the National Surgical Quality Improvement Program (NSQIP) and from patient quality of life questionnaires preoperatively and 30 days postoperatively
In this study, it is hypothesized that it is the oral antibiotics, and not the MBP, that is responsible for the reduction in postoperative infectious surgical complications (deep or superficial surgical site infection (SSI)) in patients undergoing elective colorectal resections. This improvement in postoperative infectious complications is not anticipated to result in a clinically significant increase in postoperative C. difficile infections or antibiotic resistant hospital-acquired infections.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients undergoing elective, non-emergency colon, resection surgery or abdominal perineal resection and no other requirements exists for a mechanical bowel preparation (as determined by the operating surgeon)
- •18 years of age or older
- •Able to provide oral consent
排除标准
- •Contraindication to the oral antibiotics, including allergies or adverse reactions to either metronidazole or neomycin
- •Undergoing a rectal resection with a planned anastomosis (these patients will all receive MBP)
- •Emergency surgery where no opportunity to administer preoperative oral antibiotics exists
- •Requirement for a MBP (i.e. rectal resection with pelvic anastomosis, intraoperative colonoscopy, or at the discretion of the treating surgeon
研究组 & 干预措施
No Preparation
No preparation before surgery
干预措施: No Preparation (Other)
Oral Antibiotics
Oral antibiotics (neomycin and flagyl), to be taken the day before the surgery
干预措施: Neomycin and Flagyl (Drug)
结局指标
主要结局
Post-Operative Surgical Infection Complication
时间窗: 30 days
To evaluate that use of oral antibiotics (neomycin and flagyl), administered the day prior to elective colonic resection is associated with a significant reduction in postoperative (within 30 days) surgical infectious complications (superficial and deep space infections).
次要结局
- Grade III-IV Postoperative Surgical Site Infectious Complication(30 days)
- Postoperative Infections Complications(30 days)
- Overall Postoperative Complication Rate(30 days)
- Postoperative Length of Stay(Number of days spent in hospital post-operatively, average of 6 days)
- Incidence of Postoperative C. difficile Infections(90 days)
- Incidence of Antibiotics Resistant Postoperative Infectious Complications(30 days)
- Patient Quality of Life(30 days)
- Direct Estimation of Health Utility Values(30 days)
- Incremental Cost-Effectiveness Ratio(Through to study completion, an average of 2 years)
